Itraconazole was as effective as amphotericin B for fever and neutropenia in cancer and led to fewer adverse events

Phillips, Elizabeth J.
March 2002
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p58
Academic Journal
Presents information on a study which investigated the effectiveness and safety of itraconazole as amphotericin B for eliminating fever and neutropenia in patients with cancer. Methodology of the study; Results; Comments on the outcome of the study.


Related Articles

  • Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy. Cometta, A.; Kern, W.V.; De Bock, R.; Paesmans, M.; Vandenbergh, M.; Crokaert, F.; Engelhard, D.; Marchetti, O.; Akan, H.; Skoutelis, A.; Korten, V.; Vandercam, M.; Gaya, H.; Padmos, A.; Klastersky, J.; Zinner, S.; Glauser, M.P.; Calandra, T.; Viscoli, C. // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p382 

    Assesses whether the addition of a glycopeptide would be able to reduce the time to defervescence in neutropenic patients with cancer. Patients' persistent fever after the initiation of empirical piperacillin-tazobactam monotherapy' Addition of amphotericin B to the therapy regimen; Lack of...

  • A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia. Wingard, John R.; White, Mary H.; Anaissie, Elias; Raffalli, John; Goodman, Jesse; Arrieta, Antonio // Clinical Infectious Diseases;11/1/2000, Vol. 31 Issue 5, p1155 

    Presents a study that compared safety of lipid formulations of amphoterecin B on the treatment of neutropenic patients. Most common invasive fungal infections in neutropenic patients; Characteristics of patients with febrile neutropenia enrolled in a comparative trial of empirical treatments;...

  • Editorial Response: Choosing Amphotericicin B Formulations--Between a Rock and a Hard Place. Bennett, John // Clinical Infectious Diseases;11/1/2000, Vol. 31 Issue 5, p1164 

    Editorial. Comments on a study concerning the use of lipid formulations of amphotericin B in treatment of febrile neutropenia. How the differences in toxicity were evaluated; Need for the hospitals to make rules about how their physicians select an amphotericin B formulations.

  • Amphotericin B Colloidal Dispersion Versus Amphotericin B in the Empirical Treatment of Fever and Neutropenia. Roland, William E.; White, Mary h. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p935 

    Presents a comment and a response to an article about amphotericin B colloidal dispersion versus amphotericin B in the empirical treatment of fever and neutropenia. Question on the administration of normal saline bolus to patients prior to their receiving amphotericin B; Clarification on the...

  • Liposomal amphotericin B poor value for febrile neutropenia.  // PharmacoEconomics & Outcomes News;6/2/2007, Issue 529, p9 

    The article research being done on liposomal amphotericin B. It references studies by C. D. Collins et al published in a 2007 issue of "Clinical Drug Investigation" and J. R. Wingard in the March 15, 2007 issue of the "American Journal of Health-System Pharmacy." The studies found that liposomal...

  • Rhinocerebral Phycomycosis in Association with Diabetic Ketoacidosis. Abramson, Eugene; Wilson, Dana; Arky, Ronald A. // Annals of Internal Medicine;Apr67, Vol. 66 Issue 4, p735 

    Presents two cases of rhinocerebral phycomycosis arising in association with diabetic ketoacidosis and a review of clinical and experimental experience with amphotericin B therapy. Facts of the case; Information on the amphotericin B therapy; Clinical pattern of reported cases of rhinocerebral...

  • Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Marra, Fawziah; Robbins, Graham M.; Masri, Bassam A.; Duncan, Clive; Wasan, Kishor M.; Kwong, Evan H.; Jewesson, Peter J. // Canadian Journal of Surgery;Oct2001, Vol. 44 Issue 5, p383 

    Presents a case of a patient with osteomyelitis due to Candida albicans. Treatment with amphotericin B-loaded bone cement; Removal of infected arthroplasty; Sensitivity of C. albican to amphotericin B.

  • Amphotericin B liposomal.  // Reactions Weekly;1/22/2011, Issue 1335, p7 

    The article describes the case of a 59-year-old man who experienced sensorineural hearing loss and aminotransferase elevations while undergoing treatment with amphotericin B liposomal.

  • Ciltte Yaygın Nodüler Lezyonlarla Birliktelik Gösteren Hepatosplenik Kandidiyazis: Olgu Sunumu. Karakaş, Ayşe; Tutar, Engin; Tokuç, Gülnur; Öktem, Sedat; Boran, Perran // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Mar2013, Vol. 7 Issue 1, p39 

    Hepatosplenic candidiasis (HSC), also commonly known as chronic disseminated candidiasis, is a distinct form of disseminated Candida supp. infection, with predominant involvement of the liver, spleen and occasionally the kidneys. It is detected with increasing frequency in patients who developed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics